Clinical trials
Hypoparathyroidism trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Shire | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoparathyroidism | 3 |
| Hypocalcemia | 2 |
| Calcium Metabolism Disorders | 1 |
| Endocrine System Diseases | 1 |
| Hypercalciuria | 1 |
| Metabolic Diseases | 1 |
| Muscular Diseases | 1 |
| Musculoskeletal Abnormalities | 1 |
| Musculoskeletal Diseases | 1 |
| Nephrocalcinosis | 1 |
Trials
Showing 26 to 3 of 3. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.